(Q33579623)

English

IBUFENAC IN THE TREATMENT OF ARTHRITIS

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

title

IBUFENAC IN THE TREATMENT OF ARTHRITIS (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28 July 2017

THOMPSON M

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

STEPHENSON P

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

PERCY JS

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

language of work or name

English

0 references

publication date

1 September 1964

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

published in

Annals of the Rheumatic Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

page(s)

397-404

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

cites work

A Method for Testing Analgesics in Rheumatoid Arthritis using a Sequential Procedure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010380

retrieved

21 June 2018

FAECAL BLOOD LOSS DURING TREATMENT WITH IBUFENAC, A NEW ANALGESIC DRUG.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010380

retrieved

21 June 2018

CLINICAL TRIALS OF A NEW DRUG, IBUFENAC, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRELIMINARY REPORT.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010380

retrieved

21 June 2018

The influence of treatment with sodium salicylate on the serum glutamic oxalacetic transaminase activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14206219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOME BIOLOGICAL PROPERTIES OF 'IBUFENAC', A NEW ANTI-RHEUMATIC DRUG

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14206219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/ARD.23.5.397

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

PubMed publication ID

14206219

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14206219

retrieved

28 July 2017

ResearchGate publication ID

9378428

0 references

(Q33579623)

IBUFENAC IN THE TREATMENT OF ARTHRITIS

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)